37116 Federal Register / Vol. 86, No. 132 / Wednesday, July 14, 2021 / Notices 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–21–2021] 

Foreign-Trade Zone (FTZ) 99— 

Wilmington, Delaware; Authorization of 

Production Activity; AstraZeneca 

Pharmaceuticals LP (Pharmaceutical 

Products); Newark, Delaware 

On March 11, 2021, AstraZeneca 

Pharmaceuticals LP submitted a 

notification of proposed production 

activity to the FTZ Board for its facility 

within Subzone 99D, in Newark, 

Delaware. 

The notification was processed in 

accordance with the regulations of the 

FTZ Board (15 CFR part 400), including 

notice in the Federal Register inviting 

public comment (86 FR 14867–14868, 

March 19, 2021). On July 9, 2021, the 

applicant was notified of the FTZ 

Board’s decision that no further review 

of the activity is warranted at this time. 

The production activity described in the 

notification was authorized, subject to 

the FTZ Act and the FTZ Board’s 

regulations, including Section 400.14. 

Dated: July 9, 2021. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2021–14958 Filed 7–13–21; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–53–2021] 

Foreign-Trade Zone (FTZ) 93—Raleigh/ 

Durham, North Carolina; Notification of 

Proposed Production Activity; LiebelFlarsheim Company, LLC (Diagnostic 

Imaging Contrast Media); Raleigh, 

North Carolina 

The Triangle J Council of 

Governments, grantee of FTZ 93, 

submitted a notification of proposed 

production activity to the FTZ Board on 

behalf of Liebel-Flarsheim Company, 

LLC (Liebel-Flarsheim), located in 

Raleigh, North Carolina. The 

notification conforming to the 

requirements of the regulations of the 

FTZ Board (15 CFR 400.22) was 

received on June 30, 2021. 

Liebel-Flarsheim already has 

authority to produce diagnostic imaging 

contrast media within FTZ 93. The 

current request would add a finished 

product and a foreign status material to 

the scope of authority. Pursuant to 15 

CFR 400.14(b), additional FTZ authority 

would be limited to the specific foreignstatus material and specific finished 

product described in the submitted 

notification (as described below) and 

subsequently authorized by the FTZ 

Board. 

Production under FTZ procedures 

could exempt Liebel-Flarsheim from 

customs duty payments on the foreignstatus material used in export 

production. On its domestic sales, for 

the foreign-status materials noted below 

and in the existing scope of authority, 

Liebel-Flarsheim would be able to 

choose the duty rate during customs 

entry procedures that applies to 

gadopiclenol (finished contrast media) 

(duty-free). Liebel-Flarsheim would be 

able to avoid duty on the foreign-status 

material which becomes scrap/waste. 

Customs duties also could possibly be 

deferred or reduced on foreign-status 

production equipment. 

The material sourced from abroad is 

gadopiclenol (active pharmaceutical 

ingredient) (duty rate—3.7%). The 

request indicates that the material is 

subject to duties under Section 301 of 

the Trade Act of 1974 (Section 301), 

depending on the country of origin. The 

applicable Section 301 decisions require 

subject merchandise to be admitted to 

FTZs in privileged foreign status (19 

CFR 146.41). 

Public comment is invited from 

interested parties. Submissions shall be 

addressed to the Board’s Executive 

Secretary and sent to: ftz@trade.gov. The 

closing period for their receipt is August 

23, 2021. 

A copy of the notification will be 

available for public inspection in the 

‘‘Reading Room’’ section of the Board’s 

website, which is accessible via 

www.trade.gov/ftz. 

For further information, contact Diane 

Finver at Diane.Finver@trade.gov. 

Dated: July 8, 2021. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2021–14955 Filed 7–13–21; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[S–78–2021] 

Approval of Subzone Status; Watco 

Transloading, LLC; Parsons, Kansas 

On May 18, 2021, the Executive 

Secretary of the Foreign-Trade Zones 

(FTZ) Board docketed an application 

submitted by the Board of County 

Commissioners of Sedgwick County, 

grantee of FTZ 161, requesting subzone 

status subject to the existing activation 

limit of FTZ 161, on behalf of Watco 

Transloading, LLC, in Parsons, Kansas. 

The application was processed in 

accordance with the FTZ Act and 

Regulations, including notice in the 

Federal Register inviting public 

comment (86 FR 27827, May 24, 2021). 

The FTZ staff examiner reviewed the 

application and determined that it 

meets the criteria for approval. 

Pursuant to the authority delegated to 

the FTZ Board Executive Secretary (15 

CFR 400.36(f)), the application to 

establish Subzone 161D was approved 

on July 8, 2021, subject to the FTZ Act 

and the Board’s regulations, including 

Section 400.13, and further subject to 

FTZ 161’s 2,000-acre activation limit. 

Dated: July 8, 2021. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2021–14956 Filed 7–13–21; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–52–2021] 

Foreign-Trade Zone (FTZ) 265— 

Conroe, Texas; Notification of 

Proposed Production Activity; Galdisa 

USA (Peanut Products); Conroe, Texas 

The City of Conroe, Texas, grantee of 

FTZ 265, submitted a notification of 

proposed production activity to the FTZ 

Board on behalf of Galdisa USA 

(Galdisa), located in Conroe, Texas. The 

notification conforming to the 

requirements of the regulations of the 

FTZ Board (15 CFR 400.22) was 

received on June 30, 2021. 

The Galdisa facility is located within 

FTZ 265. The facility is used for the 

production of peanut products. Galdisa 

is requesting export-only FTZ authority 

to produce peanut butter, roasted 

peanuts, peanut granules, peanut paste, 

and blanched peanuts. Pursuant to 15 

CFR 400.14(b), FTZ activity would be 

limited to the specific foreign-status 

materials and specific finished products 

described in the submitted notification 

(as described below) and subsequently 

authorized by the FTZ Board. 

Production under FTZ procedures 

could exempt Galdisa from customs 

duty payments on the foreign-status 

components used in the company’s 

export production of peanut products. 

Customs duties also could possibly be 

deferred or reduced on foreign-status 

production equipment. If the proposal 

were approved, the foreign-status sugar 

and peanuts used in the FTZ production 

for export would not be subject to 

quota(s). 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 132 / Wednesday, July 14, 2021 / Notices 37117 

1See Citric Acid and Certain Citrate Salts from 

Thailand: Preliminary Results of Antidumping Duty 

Administrative Review; 2019–2020, 86 FR 17122 

(April 1, 2021) (Preliminary Results), and 

accompanying Preliminary Decision Memorandum. 

2See Preliminary Results, 86 FR at 17123. 

3See Citric Acid and Certain Citrate Salts from 

Thailand: Partial Recission of Antidumping Duty 

Administrative Review; 2019–2020, 86 FR 7989 

(February 3, 2021). 

The components and materials 

sourced from abroad include: Raw 

peanuts in shell; beet sugar; cane sugar; 

sugar (not raw); salt; crude peanut oil; 

non-crude peanut oil; raw peanuts 

shelled; and, blanched peanuts (duty 

rate ranges from free to 163.8% (exquota rate)). The request indicates that 

certain materials/components are 

subject to duties under Section 301 of 

the Trade Act of 1974 (Section 301), 

depending on the country of origin. The 

applicable Section 301 decisions require 

subject merchandise to be admitted to 

FTZs in privileged foreign status (19 

CFR 146.41). 

Public comment is invited from 

interested parties. Submissions shall be 

addressed to the Board’s Executive 

Secretary and sent to: ftz@trade.gov. The 

closing period for their receipt is August 

23, 2021. 

A copy of the notification will be 

available for public inspection in the 

‘‘Reading Room’’ section of the Board’s 

website, which is accessible via 

www.trade.gov/ftz. 

For further information, contact Diane 

Finver at Diane.Finver@trade.gov or 

(202) 482–1367. 

Dated: July 8, 2021. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2021–14954 Filed 7–13–21; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

Bureau of Industry and Security 

Information Systems Technical 

Advisory Committee; Notice of Meeting 

The Information Systems Technical 

Advisory Committee (ISTAC) will meet 

on July 28 and 29, 2021, at 1:00 p.m., 

Eastern Daylight Time. The meetings 

will be available via teleconference. The 

Committee advises the Office of the 

Assistant Secretary for Export 

Administration on technical questions 

that affect the level of export controls 

applicable to information systems 

equipment and technology. 

Wednesday, July 28 

Open Session 

1. Welcome and Announcements 

2. Working Group Reports 

3. New Business 

Thursday, July 29: 

Closed Session 

4. Discussion of matters determined to 

be exempt from the provisions 

relating to public meetings found in 

5 U.S.C. app. 2 §§ 10(a)(1) and 

10(a)(3). 

The open session will be accessible 

via teleconference. To join the 

conference, submit inquiries to Ms. 

Yvette Springer at Yvette.Springer@

bis.doc.gov, no later than July 21, 2021. 

To the extent time permits, members 

of the public may present oral 

statements to the Committee. The public 

may submit written statements at any 

time before or after the meeting. 

However, to facilitate distribution of 

public presentation materials to 

Committee members, the Committee 

suggests that public presentation 

materials or comments be forwarded 

before the meeting to Ms. Springer. 

For more information, call Yvette 

Springer at (202) 482–2813. 

Yvette Springer, 

Committee Liaison Officer. 

[FR Doc. 2021–14959 Filed 7–13–21; 8:45 am] 

BILLING CODE 3510–JT–P 

DEPARTMENT OF COMMERCE 

International Trade Administration 

[A–549–833] 

Citric Acid and Certain Citrate Salts 

From Thailand: Final Results of 

Antidumping Duty Administrative 

Review; 2019–2020 

AGENCY: Enforcement and Compliance, 

International Trade Administration, 

Department of Commerce. 

SUMMARY: The Department of Commerce 

(Commerce) determines that sales of 

citric acid and certain citrate salts (citric 

acid) from Thailand have not been made 

at less than normal value by COFCO 

Biochemical (Thailand) Co., Ltd. 

(COFCO) or Sunshine Biotech 

International Co., Ltd. (Sunshine) 

during the period of review (POR), July 

1, 2019, through June 30, 2020. 

DATES: Applicable July 14, 2021. 

FOR FURTHER INFORMATION CONTACT: Joy 

Zhang or Patrick Barton, AD/CVD 

Operations, Office III, Enforcement and 

Compliance, International Trade 

Administration, U.S. Department of 

Commerce, 1401 Constitution Avenue 

NW, Washington, DC 20230; telephone: 

(202) 482–1168 or (202) 482–0012, 

respectively. 

SUPPLEMENTARY INFORMATION: 

Background 

On April 1, 2021, Commerce 

published the Preliminary Results.1 We 

invited interested parties to comment on 

the Preliminary Results.2 This review 

covers three respondents: COFCO, Niran 

(Thailand) Co., Ltd. (Niran), and 

Sunshine. Commerce rescinded this 

review, in part, with respect to Niran on 

February 3, 2021.3 No interested party 

submitted comments on the Preliminary 

Results. Accordingly, the final results 

remain unchanged from the Preliminary 

Results. Commerce conducted this 

review in accordance with section 751 

of the Tariff Act of 1930, as amended 

(the Act). 

Scope of the Order 

The merchandise covered by the order 

is citric acid and certain citrate salts 

from Thailand. The scope of the order 

includes all grades and granulation sizes 

of citric acid, sodium citrate, and 

potassium citrate in their unblended 

forms, whether dry or in solution, and 

regardless of packaging type. The scope 

also includes blends of citric acid, 

sodium citrate, and potassium citrate; as 

well as blends with other ingredients, 

such as sugar, where the unblended 

form(s) of citric acid, sodium citrate, 

and potassium citrate constitute 40 

percent or more, by weight, of the blend. 

The scope also includes all forms of 

crude calcium citrate, including 

dicalcium citrate monohydrate, and 

tricalcium citrate tetrahydrate, which 

are intermediate products in the 

production of citric acid, sodium citrate, 

and potassium citrate. 

The scope includes the hydrous and 

anhydrous forms of citric acid, the 

dihydrate and anhydrous forms of 

sodium citrate, otherwise known as 

citric acid sodium salt, and the 

monohydrate and monopotassium forms 

of potassium citrate. Sodium citrate also 

includes both trisodium citrate and 

monosodium citrate which are also 

known as citric acid trisodium salt and 

citric acid monosodium salt, 

respectively. 

The scope does not include calcium 

citrate that satisfies the standards set 

forth in the United States Pharmacopeia 

and has been mixed with a functional 

excipient, such as dextrose or starch, 

where the excipient constitutes at least 

2 percent, by weight, of the product. 

Citric acid and sodium citrate are 

classifiable under 2918.14.0000 and 

2918.15.1000 of the Harmonized Tariff 

Schedule of the United States (HTSUS), 


lotter on DSK11XQN23PROD with NOTICES1